Guru Ownership Trend
Guru Analysis for Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals, Inc. (CPRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $98.49 M.
Top institutional holders include Renaissance Technologies (RenTech) and Chuck Royce.
Institutional sentiment is currently Bearish. This is evidenced by a $89.19 M net outflow during the quarter.
Recent activity highlights George Soros who opened a new position. Conversely, Chuck Royce reduced exposure by 82.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Catalyst Pharmaceuticals, Inc. (CPRX)
Major holders include Renaissance Technologies (RenTech) ($67.14 M), Chuck Royce ($11.27 M), George Soros ($10.83 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 3.13 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $89.19 M, with 2 managers increasing positions and 9 managers reducing holdings.
During the most recent reporting period, 5 managers trimmed their positions, while 4 fully exited CPRX. The total reported sell value was $100.46 M.
Yes, 2 managers opened new positions in CPRX, and 0 increased their existing holdings. The total reported buy value was $11.27 M.
